Zonghai Li

6 ta ish

Regend Therapeutics (China)

1. Circular orbit of a particle and weak gravitational lensing

   Zonghai Li, Guodong Zhang, Ali Övgün

   MaqolaOAOchiq kirish202012 iqtibos

   ABIABI:AkademIndex/2026.other.023278

2. Finite-distance gravitational deflection of massive particles by a Kerr-like black hole in the bumblebee gravity model

   Zonghai Li, Ali Övgün

   MaqolaOAOchiq kirish202010 iqtibos

   ABIABI:AkademIndex/2026.other.023277

3. Kerr-Newman-Jacobi geometry and the deflection of charged massive particles

   Zonghai Li, Junji Jia

   MaqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.023317

4. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

   Changsong Qi, Jifang Gong, Jian Li +23

   MaqolaOAOchiq kirish20223 iqtibos

   ABIABI:AkademIndex/2026.other.102908

5. Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

   Changsong Qi, Chang Liu, Zhi Peng +31

   MaqolaOAOchiq kirish20252 iqtibos

   ABIABI:AkademIndex/2026.other.103004

6. Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

   Hua Jiang, Zhimin Shi, Peng Wang +9

   Maqola20182 iqtibos

   ABIABI:AkademIndex/2026.other.431542